SwePub
Sök i LIBRIS databas

  Extended search

L773:1019 6439
 

Search: L773:1019 6439 > Feasibility of imag...

Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with Tc-99m using a peptide-based cysteine-containing chelator

Andersson, Ken G. (author)
KTH,Proteinteknologi,KTH Royal Inst Technol, Div Prot Technol, SE-10691 Stockholm, Sweden
Oroujeni, Maryam (author)
Uppsala universitet,Medicinsk strålningsvetenskap,Vladimir Tolmachev
Garousi, Javad (author)
Uppsala universitet,Medicinsk strålningsvetenskap,Vladimir Tolmachev
show more...
Mitran, Bogdan (author)
Uppsala universitet,Avdelningen för Molekylär Avbildning,Anna Orlova
Ståhl, Stefan (author)
KTH,Proteinteknologi,KTH Royal Inst Technol, Div Prot Technol, SE-10691 Stockholm, Sweden
Orlova, Anna (author)
Uppsala universitet,Avdelningen för Molekylär Avbildning,Anna Orlova
Löfblom, John (author)
KTH,Proteinteknologi,KTH Royal Inst Technol, Div Prot Technol, SE-10691 Stockholm, Sweden
Tolmachev, Vladimir (author)
Uppsala universitet,Medicinsk strålningsvetenskap,Vladimir Tolmachev
show less...
 (creator_code:org_t)
2016-10-05
2016
English.
In: International Journal of Oncology. - : SPANDIDOS. - 1019-6439 .- 1791-2423. ; 49:6, s. 2285-2293
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The epidermal growth factor receptor (EGFR) is overexpressed in a number of malignant tumors and is a molecular target for several specific anticancer antibodies and tyrosine kinase inhibitors. The overexpression of EGFR is a predictive biomarker for response to several therapy regimens. Radionuclide molecular imaging might enable detection of EGFR overexpression by a non-invasive procedure and could be used repeatedly. Affibody molecules are engineered scaffold proteins, which could be selected to have a high affinity and selectivity to predetermined targets. The anti-EGFR ZEGFR:2377 affibody molecule is a potential imaging probe for EGFR detection. The use of the generator-produced radionuclide Tc-99m should facilitate clinical translation of an imaging probe due to its low price, availability and favorable dosimetry of the radionuclide. In the present study, we evaluated feasibility of ZEGFR:2377 labeling with Tc-99m using a peptide-based cysteine-containing chelator expressed at the C-terminus of ZEGFR:2377. The label was stable in vitro under cysteine challenge. In addition, Tc-99m-ZEGFR:2377 was capable of specific binding to EGFR-expressing cells with high affinity (274 pM). Studies in BALB/C nu/nu mice bearing A431 xenografts demonstrated that Tc-99m-ZEGFR:2377 accumulates in tumors in an EGFR-specific manner. The tumor uptake values were 3.6 1 and 2.5 0.4% ID/g at 3 and 24 h after injection, respectively. The corresponding tumor-to-blood ratios were 1.8 0.4 and 8 3. The xenografts were clearly visualized at both time-points. This study demonstrated the potential of Tc-99m-labeled ZEGFR:2377 for imaging of EGFR in vivo.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Andra medicinska och farmaceutiska grundvetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Other Basic Medicine (hsv//eng)

Keyword

epidermal growth factor receptor
radionuclide molecular imaging
affibody molecules
technetium-99m
A431
biodistribution

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view